Loading organizations...
Sucden Ventures operates as a venture capital specialist, dedicating its efforts to identifying and funding innovative, early-stage growth companies within the expansive food and agricultural sector. The firm strategically deploys capital into enterprises developing sustainable solutions and disruptive technologies designed to transform the future of global food production and supply chains, extending the core capabilities of its parent organization into novel areas.
Established in 2020, Sucden Ventures emerged as the corporate venture capital arm of Sucres & Denrées, widely known as Sucden, a prominent independent leader in soft commodities trading. This initiative was born from the insight that leveraging Sucden's deep industry knowledge and extensive network could accelerate the development and adoption of new technologies crucial for evolving the food and agriculture landscape. The venture capital entity draws on its parent company's long-standing expertise in global markets.
The beneficiaries of Sucden Ventures' investments are groundbreaking startups and emerging companies poised to redefine agricultural practices and food systems. The firm’s overarching mission is to foster innovation that creates a more efficient, resilient, and environmentally conscious future for food and agriculture worldwide. It aims to propel forward-looking solutions that address pressing global challenges, securing a sustainable path for the industry.
Sucden Ventures has 3 tracked investments across 1 company. The latest tracked deal is $105.0M Series C in Tropic Biosciences in March 2026.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Mar 15, 2026 | Tropic Biosciences | $105.0M Series C | TOM Greene, JOY Faucher | ABN AMRO, Five Seasons Ventures, Genoa Ventures, Invest International, Alex Wilson, Siddarth Shrikanth, Polaris Partners, Pontifax AgTech, Temasek |
| Jul 6, 2022 | Tropic Biosciences | $35.0M Other Equity | Bjoern Witte | ADQ, Bloom8, Skyviews Life Science, Tekfen Ventures |
| Jul 1, 2022 | Tropic Biosciences | $35.0M Series C | Blue Horizon | Genoa Ventures, Tekfen Ventures, TAZ Patel, ADQ, Bloom8, Skyviews Life Science |